Device Trial Radar · NCT02463279
SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study
Last checked: Nov 20, 2026Latest source record: Dec 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- SinuSys CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 4, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate basic usability and confirm expected safety and effectiveness of SinuSys Dilation System when used to dilate frontal recess and sphenoid sinus ostia in patients with chronic rhinosinusitis.
Conditions
- Sinusitis
Interventions
Sinusys Dilation SystemDevice
Dilation of frontal recess and/or sphenoid sinus ostia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patency of treated target siteTime frame: Patency immediately post device expansion and removal
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Upland ENT
Upland, California
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.